Main Article Content
Abstract
Diabetic neuropathy is a common complication of diabetes mellitus and a major contributing factor to the development of diabetic foot ulcers (DFU). Apolipoproteins A1 (ApoA1) and B (ApoB), as well as the ApoB/ApoA1 ratio, play a crucial role in lipid metabolism and are believed to be involved in the development of neuropathic damage in individuals with diabetes. This study highlights the association between ApoA1, ApoB, and the ApoB/ApoA1 ratio with the risk of developing diabetic neuropathy. A systematic review was conducted following the PRISMA guidelines. An extensive literature search was conducted on December 7, 2024, using multiple databases, including PubMed, ProQuest, EBSCOhost, and Medline. There were no language or publication date restrictions. This synthesis relied solely on odds ratios (ORs) with 95% confidence intervals (CIs) as effect sizes. Included studies were observational in design, examining the association between ApoA1, ApoB, or the ApoB/ApoA1 ratio with diabetic neuropathy in an adult population. Of the 320 studies identified, 5 met the criteria for inclusion in the qualitative synthesis and meta-analysis, involving 2,756 diabetic patients. Findings showed higher ApoB levels and lower ApoA1 levels in patients with diabetic neuropathy compared with controls. However, no significant association was found between ApoB, ApoA1, or the ApoB/ApoA1 ratio with diabetic neuropathy or DFU risk. This review found no significant association between ApoB, ApoA1, or the ApoB/ApoA1 ratio with diabetic neuropathy or DFU. Further research is needed to explore their potential role in DM complications.
Keywords
Article Details
Copyright (c) 2025 Ervina Gosal, Tena Djuartina, Alfred Sutrisno, Iskandar R. Budianto
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in the Jurnal Kedokteran dan Kesehatan Indonesia agree to the following terms:
- Authors retain copyright and grant Jurnal Kedokteran dan Kesehatan Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
- Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.